Wellington Management Group LLP Autolus Therapeutics PLC Transaction History
Wellington Management Group LLP
- $529 Billion
- Q2 2025
A detailed history of Wellington Management Group LLP transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Wellington Management Group LLP holds 27,147,035 shares of AUTL stock, worth $58.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,147,035
Previous 27,091,700
0.2%
Holding current value
$58.4 Million
Previous $42 Million
47.4%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding AUTL
# of Institutions
99Shares Held
165MCall Options Held
0Put Options Held
39.3K-
Blackstone Inc New York, NY20.5MShares$44 Million0.22% of portfolio
-
Mak Capital One LLC New York, NY17MShares$36.5 Million5.54% of portfolio
-
Deep Track Capital, LP Greenwich, CT16.9MShares$36.2 Million1.36% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$35.8 Million98.24% of portfolio
-
Armistice Capital, LLC New York, NY12MShares$25.8 Million0.48% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $195M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...